CellaVision AB
STO:CEVI
CellaVision AB
STO:CEVI
Price:
150.2
SEK
Market Closed
Market Cap:
kr3.6B
Relative Value
The Relative Value of one
CEVI
stock under the Base Case scenario is
hidden
SEK.
Compared to the current market price of 150.2 SEK,
CellaVision AB
is
hidden
.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
CEVI Relative Value
HIDDEN
Multiples Across Competitors
CEVI Competitors Multiples
CellaVision AB Competitors
CellaVision AB Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| SE |
|
CellaVision AB
STO:CEVI
|
3.6B SEK | 4.7 | 23.4 | 16.9 | 16.9 | |
| US |
|
Abbott Laboratories
NYSE:ABT
|
193.3B USD | 4.4 | 29.6 | 16.9 | 23.3 | |
| US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
172.1B USD | 17 | 60 | 45.5 | 56 | |
| US |
|
Stryker Corp
NYSE:SYK
|
134.8B USD | 5.3 | 41.3 | 21 | 25.4 | |
| IE |
|
Medtronic PLC
NYSE:MDT
|
113.8B USD | 3.2 | 24.6 | 13.6 | 19.8 | |
| US |
|
Boston Scientific Corp
NYSE:BSX
|
106.2B USD | 5.3 | 36.4 | 21.4 | 28.7 | |
| DE |
|
Siemens Healthineers AG
XETRA:SHL
|
43.4B EUR | 1.9 | 20.6 | 11.5 | 16.2 | |
| US |
|
Edwards Lifesciences Corp
NYSE:EW
|
48.7B USD | 8.1 | 45.6 | 25.1 | 27.5 | |
| US |
|
IDEXX Laboratories Inc
NASDAQ:IDXX
|
47.3B USD | 10.9 | 44.2 | 31.3 | 34.6 | |
| US |
|
Becton Dickinson and Co
NYSE:BDX
|
46.4B USD | 2.1 | 26.2 | 10.3 | 17.4 | |
| US |
|
Resmed Inc
NYSE:RMD
|
34.1B USD | 6.3 | 22.9 | 16.1 | 17.9 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
